Abstract:Objective To explore the expression of microRNA-98 (miR-98) in human neuroblastoma cell line SH-SY5Y and its relationship with cell apoptosis and inflammatory injury in ischemic stroke.Methods Oxygen-glucose deprivation/reperfusion (OGD/R) was used to induce SH-SY5Y cells to establish an in vitro cell model of ischemic stroke. The cells were divided into control group (without any treatment) and OGD/R group. Cell viability was detected by MTT assay. The expression levels of miR-98 and Rho-associated coiled-coil kinase 2 (ROCK2) were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Bioinformatics methods were used to screen miRNAs that specifically bind to ROCK2 with high stability, and dual-luciferase reporter gene assay was performed to detect luciferase activity. The relative expression level of ROCK2 protein was detected by Western blotting. miR-98 mimics, miR-98 inhibitors, pcDNA3.1-ROCK2 and their corresponding negative controls were transfected into SH-SY5Y cells, followed by OGD/R treatment. Flow cytometry and TUNEL assay were used to detect cell apoptosis. Absorptiometry was used to determine the levels of apoptotic-related proteins Caspase-3 and Caspase-9. The mRNA expression levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were detected by qRT-PCR.Results Compared with the control group, the OGD/R group showed decreased cell viability, reduced relative expression level of miR-98 (P < 0.05), and increased relative expression level of ROCK2 mRNA (P < 0.05). Combined bioinformatics analysis and dual-luciferase reporter gene assay confirmed that ROCK2 is one of the target genes of miR-98 (P < 0.05). Compared with the control group, the miR-98 mimics transfection group had an increased relative expression level of miR-98 mRNA (P < 0.05) and a decreased relative expression level of ROCK2 protein (P < 0.05); the miR-98 inhibitor transfection group had a decreased relative expression level of miR-98 mRNA and an increased relative expression level of ROCK2 protein (P < 0.05). Compared with the control group, the OGD/R group had increased cell apoptosis rate and elevated levels of Caspase-3 and Caspase-9 (P < 0.05); compared with the mimic control group, the miR-98 mimics group had decreased cell apoptosis rate and reduced levels of Caspase-3 and Caspase-9 (P < 0.05); compared with the miR-98 mimics group, the miR-98 mimics + pcDNA3.1-ROCK2 group had increased cell apoptosis rate and elevated levels of Caspase-3 and Caspase-9 (P < 0.05). Compared with the control group, the OGD/R group had increased mRNA expression levels of TNF-α and IL-6 (P < 0.05); compared with the mimic control group, the miR-98 mimics group had decreased mRNA expression levels of TNF-α and IL-6 (P < 0.05); compared with the miR-98 mimics group, the miR-98 mimics + pcDNA3.1-ROCK2 group had increased mRNA expression levels of TNF-α and IL-6 (P < 0.05).Conclusion miR-98 inhibits apoptosis and inflammatory injury of human neuroblastoma SH-SY5Y cells by targeting and inhibiting the expression of ROCK2, thereby exerting a protective effect against neuronal injury in ischemic stroke.